Pursuant to Regulations - 7(1)(b) of SEBI (Prohibition of Insider Trading) Regulations, 2015, we enclose herewith disclosures in prescribed Form - B.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Chennai Meenakshi Multispeciality Hospital has submitted a regulatory disclosure under SEBI's Prohibition of Insider Trading Regulations regarding four newly appointed directors, all effective from September 30, 2025. The new directors are Edward M. Prabhakar (DIN: 11237027), Akash Prabhakar (DIN: 09787348), Shama Dhilip (DIN: 11252717), and K.M. Mohandass (DIN: 00707839). Of these, only Akash Prabhakar holds securities in the company — 37,000 equity shares representing 0.50% of shareholding. The other three directors reported no shareholding in the company at the time of appointment. All four directors reported nil open interest in futures and options contracts. The disclosure was filed by R. Gomathi, Chairman and Managing Director, on October 6, 2025.
This is a routine compliance filing disclosing the shareholdings of four newly appointed directors. Only one director (Akash Prabhakar) holds a small stake of 0.50%, so there is no significant insider buying signal. Shareholders may note the board expansion, but no material impact on stock price is expected from this disclosure alone.